rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

524804 AUROBINDOP Group (A)

Aurobindo Pharma Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
679.00   -13.00   -1.88%
Volume 122,989
Prev close 692.00
Day's H/L (Rs.) 704.00 - 671.00
52wk H/L (Rs.) 786.50 - 138.45
Mkt Cap (Rs. Cr) 19,792.85
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

AUROPHARMA

Aurobindo Pharma Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
677.90   -14.05   -2.03%
Volume 1,297,620
Prev close 691.95
Day's H/L (Rs.) 704.45 - 668.85
52wk H/L (Rs.) 787.30 - 138.35
Turnover (Rs. Lacs) 8,872.22
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Aurobindo Pharma Ltd.  (See all 1,750 market voices)   

140 Characters
  Cancel
Prasant Numerology - 16 hour(s) ago as warned 2 weeks ago, period of number 1 begins from jul 20. And auropharma is 1.but afflicted form. So, highly risky for innocent traders
#Aurobindo-Pharma-Ltd
Reply   |   Share
Prasant Numerology - 16 hour(s) ago as warned 2 weeks ago, period of number 1 begins from jul 20. And auropharma is 1.but afflicted form. So, highly risky for innocent traders
#Aurobindo-Pharma-Ltd
Reply   |   Share

Realtime news for Aurobindo Pharma Ltd. (See all 469 news)

29 July 2014, 08:06
Pfizer, ViiV drag Aurobindo to court over patents - 1 hour(s) ago
Aurobindo Pharma to hold board meeting - 21 Jul 2014
India Pharmaceutical Market 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMs), Biosimilars, Generics & Vaccines - 21 Jul 2014
Cipla, Aurobindo,Emcure to supply HIV drugs for UN-backed prog - 17 Jul 2014
Sharekhan positive on pharma; prefers Aurobindo, Torrent - 15 Jul 2014

BSE Announcements from Aurobindo Pharma Ltd. (See all)

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 - 15 Jul 2014
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 - 14 Jul 2014

Company details for Aurobindo Pharma Ltd.

Report Card

PE Ratios
17.21
EPS (Rs.)
40.21
Sales (Rs. Cr)
2,003.02
Face Value (Rs.)
1
Net Profit
Margin (%)
 
9.09
Last Bonus
1:1
Last Dividend(%)
175
Return on
Average Equity
 
16.87

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Aurobindo Pharma Ltd. with other stocks

Apollo Hospitals Enterprise Ltd.
1,082.20
Biocon Ltd.
516.85
Show more companies
Apollo Hospitals Enterprise Ltd.
1,082.20
Biocon Ltd.
516.85
Cadila Healthcare Ltd.
1,097.70
Divi's Laboratories Ltd.
1,501.15
Dr. Reddy's Laboratories Ltd.
2,710.55
GlaxoSmithKline Pharmaceuticals Ltd.
2,478.40
Ipca Laboratories Ltd.
727.65
Ranbaxy Laboratories Ltd.
561.30
Cipla Ltd.
439.30
Glenmark Pharmaceuticals Ltd.
596.25
Show less companies
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close